Figure 3.
Higher sustained virologic response rates of combination treatment of glecaprevir/pibrentasvir for patients with or without dialysis in the present study.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.